Ihara Science Corporation Logo

Ihara Science Corporation

5999.T

(3.2)
Stock Price

2.976,00 JPY

6.51% ROA

7.88% ROE

16.8x PER

Market Cap.

32.076.816.000,00 JPY

1.26% DER

0% Yield

15.94% NPM

Ihara Science Corporation Stock Analysis

Ihara Science Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ihara Science Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (16.6%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a low debt to equity ratio (1%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 PBV

The stock's PBV ratio (1.3x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

9 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (20.656), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Ihara Science Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ihara Science Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Ihara Science Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ihara Science Corporation Revenue
Year Revenue Growth
2008 13.805.000.000
2009 10.673.000.000 -29.35%
2010 6.556.000.000 -62.8%
2011 10.527.000.000 37.72%
2012 10.249.000.000 -2.71%
2013 9.158.000.000 -11.91%
2014 10.798.000.000 15.19%
2015 11.153.000.000 3.18%
2016 12.201.000.000 8.59%
2017 13.533.000.000 9.84%
2018 16.695.000.000 18.94%
2019 17.714.000.000 5.75%
2020 15.054.000.000 -17.67%
2021 14.424.000.000 -4.37%
2022 20.607.000.000 30%
2023 25.508.000.000 19.21%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ihara Science Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ihara Science Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ihara Science Corporation EBITDA
Year EBITDA Growth
2008 3.054.000.000
2009 1.802.000.000 -69.48%
2010 826.000.000 -118.16%
2011 2.171.000.000 61.95%
2012 1.649.000.000 -31.66%
2013 1.522.000.000 -8.34%
2014 2.011.000.000 24.32%
2015 2.038.000.000 1.32%
2016 2.275.000.000 10.42%
2017 2.851.000.000 20.2%
2018 3.629.000.000 21.44%
2019 3.790.000.000 4.25%
2020 3.142.000.000 -20.62%
2021 3.227.000.000 2.63%
2022 5.125.000.000 37.03%
2023 5.104.000.000 -0.41%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ihara Science Corporation Gross Profit
Year Gross Profit Growth
2008 4.605.000.000
2009 3.057.000.000 -50.64%
2010 1.680.000.000 -81.96%
2011 3.480.000.000 51.72%
2012 3.096.000.000 -12.4%
2013 2.722.000.000 -13.74%
2014 3.476.000.000 21.69%
2015 3.519.000.000 1.22%
2016 3.852.000.000 8.64%
2017 4.409.000.000 12.63%
2018 5.462.000.000 19.28%
2019 5.509.000.000 0.85%
2020 4.591.000.000 -20%
2021 4.323.000.000 -6.2%
2022 6.579.000.000 34.29%
2023 7.532.000.000 12.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ihara Science Corporation Net Profit
Year Net Profit Growth
2008 1.455.000.000
2009 727.000.000 -100.14%
2010 256.000.000 -183.98%
2011 1.087.000.000 76.45%
2012 699.000.000 -55.51%
2013 760.000.000 8.03%
2014 1.047.000.000 27.41%
2015 1.022.000.000 -2.45%
2016 1.050.000.000 2.67%
2017 1.734.000.000 39.45%
2018 2.498.000.000 30.58%
2019 2.481.000.000 -0.69%
2020 1.880.000.000 -31.97%
2021 2.146.000.000 12.4%
2022 3.312.000.000 35.21%
2023 3.760.000.000 11.91%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ihara Science Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 109
2009 57 -91.23%
2010 22 -171.43%
2011 93 77.17%
2012 60 -55.93%
2013 65 9.23%
2014 90 26.97%
2015 87 -3.49%
2016 95 9.47%
2017 170 43.79%
2018 244 30.74%
2019 242 -1.24%
2020 180 -34.64%
2021 203 11.82%
2022 309 34.3%
2023 349 11.46%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ihara Science Corporation Free Cashflow
Year Free Cashflow Growth
2008 1.321.000.000
2009 1.324.000.000 0.23%
2010 403.000.000 -228.54%
2011 562.000.000 28.29%
2012 -1.443.000.000 138.95%
2013 1.112.000.000 229.77%
2014 1.000.000 -111100%
2015 1.119.000.000 99.91%
2016 350.000.000 -219.71%
2017 483.000.000 27.54%
2018 522.000.000 7.47%
2019 1.699.000.000 69.28%
2020 848.000.000 -100.35%
2021 2.485.000.000 65.88%
2022 532.000.000 -367.11%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ihara Science Corporation Operating Cashflow
Year Operating Cashflow Growth
2008 1.763.000.000
2009 1.550.000.000 -13.74%
2010 586.000.000 -164.51%
2011 643.000.000 8.86%
2012 342.000.000 -88.01%
2013 1.372.000.000 75.07%
2014 97.000.000 -1314.43%
2015 1.334.000.000 92.73%
2016 939.000.000 -42.07%
2017 1.600.000.000 41.31%
2018 1.345.000.000 -18.96%
2019 3.261.000.000 58.75%
2020 2.170.000.000 -50.28%
2021 2.685.000.000 19.18%
2022 973.000.000 -175.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ihara Science Corporation Capital Expenditure
Year Capital Expenditure Growth
2008 442.000.000
2009 226.000.000 -95.58%
2010 183.000.000 -23.5%
2011 81.000.000 -125.93%
2012 1.785.000.000 95.46%
2013 260.000.000 -586.54%
2014 96.000.000 -170.83%
2015 215.000.000 55.35%
2016 589.000.000 63.5%
2017 1.117.000.000 47.27%
2018 823.000.000 -35.72%
2019 1.562.000.000 47.31%
2020 1.322.000.000 -18.15%
2021 200.000.000 -561%
2022 441.000.000 54.65%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ihara Science Corporation Equity
Year Equity Growth
2008 7.336.000.000
2009 6.937.000.000 -5.75%
2010 6.966.000.000 0.42%
2011 7.872.000.000 11.51%
2012 8.395.000.000 6.23%
2013 8.964.000.000 6.35%
2014 9.928.000.000 9.71%
2015 10.844.000.000 8.45%
2016 10.265.000.000 -5.64%
2017 11.907.000.000 13.79%
2018 14.271.000.000 16.57%
2019 16.161.000.000 11.69%
2020 17.521.000.000 7.76%
2021 19.308.000.000 9.26%
2022 22.178.000.000 12.94%
2023 24.712.000.000 10.25%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ihara Science Corporation Assets
Year Assets Growth
2008 13.086.000.000
2009 11.637.000.000 -12.45%
2010 11.540.000.000 -0.84%
2011 12.798.000.000 9.83%
2012 14.096.000.000 9.21%
2013 13.687.000.000 -2.99%
2014 14.472.000.000 5.42%
2015 15.037.000.000 3.76%
2016 15.928.000.000 5.59%
2017 17.279.000.000 7.82%
2018 21.968.000.000 21.34%
2019 22.230.000.000 1.18%
2020 22.674.000.000 1.96%
2021 24.092.000.000 5.89%
2022 27.630.000.000 12.8%
2023 29.719.000.000 7.03%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ihara Science Corporation Liabilities
Year Liabilities Growth
2008 5.750.000.000
2009 4.700.000.000 -22.34%
2010 4.574.000.000 -2.75%
2011 4.926.000.000 7.15%
2012 5.701.000.000 13.59%
2013 4.723.000.000 -20.71%
2014 4.544.000.000 -3.94%
2015 4.193.000.000 -8.37%
2016 5.663.000.000 25.96%
2017 5.372.000.000 -5.42%
2018 7.695.000.000 30.19%
2019 6.069.000.000 -26.79%
2020 5.153.000.000 -17.78%
2021 4.784.000.000 -7.71%
2022 5.452.000.000 12.25%
2023 5.007.000.000 -8.89%

Ihara Science Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1111.05
Net Income per Share
177.12
Price to Earning Ratio
16.8x
Price To Sales Ratio
2.68x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
1.3
EV to Sales
2.08
EV Over EBITDA
9.55
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.06
FreeCashFlow Yield
0
Market Cap
32,08 Bil.
Enterprise Value
24,90 Bil.
Graham Number
3021.89
Graham NetNet
880.08

Income Statement Metrics

Net Income per Share
177.12
Income Quality
0
ROE
0.08
Return On Assets
0.06
Return On Capital Employed
0.09
Net Income per EBT
0.73
EBT Per Ebit
1.08
Ebit per Revenue
0.2
Effective Tax Rate
0.26

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.3
Operating Profit Margin
0.2
Pretax Profit Margin
0.22
Net Profit Margin
0.16

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.07
Return on Tangible Assets
0.07
Days Sales Outstanding
159.79
Days Payables Outstanding
62.34
Days of Inventory on Hand
266.14
Receivables Turnover
2.28
Payables Turnover
5.85
Inventory Turnover
1.37
Capex per Share
0

Balance Sheet

Cash per Share
696,12
Book Value per Share
2.291,42
Tangible Book Value per Share
2296.44
Shareholders Equity per Share
2291.42
Interest Debt per Share
29.18
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-2.75
Current Ratio
6.16
Tangible Asset Value
24,27 Bil.
Net Current Asset Value
14,83 Bil.
Invested Capital
0.01
Working Capital
16,61 Bil.
Intangibles to Total Assets
0.01
Average Receivables
5,16 Bil.
Average Payables
1,52 Bil.
Average Inventory
5989500000
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ihara Science Corporation Dividends
Year Dividends Growth
2003 0
2004 0 0%
2007 0 0%
2008 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Ihara Science Corporation Profile

About Ihara Science Corporation

Ihara Science Corporation manufactures and sells fittings, valves, hoses, and pipes primarily in Japan, Taiwan, China, South Korea, North America, Southeast Asia, Europe, and Australia. It offers fittings, including double ferule type tube fittings, resin tube fittings, vinyl hose and weldless fittings, automatic weld fittings, metal gasket seal type fittings, metal gasket seal fittings, and swivel joints, as well as quick joint fittings, biting fittings, high-pressure screw-in/insert welded joint, hose joint, branch header piping, and inline filter. The company also provides bellow and metal diaphragm, ball, stop, stainless check, and piston valves; metal flexible tubes, precision carbon steel galvanized steel pipe, and stainless steel tubes; and tube cutters and pre-setting devices. The company was formerly known as Ihara High Pressure Fittings Co.,Ltd. and changed its name to Ihara Science Corporation in October 1997. Ihara Science Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

CEO
Mr. Tokuo Nakano
Employee
584
Address
3-11-3 Takanawa
Tokyo, 108-0074

Ihara Science Corporation Executives & BODs

Ihara Science Corporation Executives & BODs
# Name Age
1 Mr. Toshihiro Imakubo
Executive Officer, Mngr of IPEC Bus. Dept and Mngr of IPEC Shizuoka Bus. Office
70
2 Mr. Satoshi Nagaoka
Pres & Director
70
3 Mr. Tokuo Nakano
Chairman and Chief Operating Officer
70
4 Mr. Katsuyuki Hioki
Executive Officer, Mang. of Shizuoka Bus. Office & Mang. of Cp Bus. Dept
70
5 Mr. Sumihiko Iwamoto
Executive Officer & Mang. of Domestic Sales Department
70

Ihara Science Corporation Competitors